Lam Research Corporation

BASE:LRCX Stock Report

Market Cap: AR$99.8t

Lam Research Balance Sheet Health

Financial Health criteria checks 6/6

Lam Research has a total shareholder equity of $8.5B and total debt of $5.0B, which brings its debt-to-equity ratio to 58.8%. Its total assets and total liabilities are $19.5B and $11.1B respectively. Lam Research's EBIT is $4.6B making its interest coverage ratio -57.7. It has cash and short-term investments of $6.1B.

Key information

58.8%

Debt to equity ratio

US$4.98b

Debt

Interest coverage ratio-57.7x
CashUS$6.07b
EquityUS$8.47b
Total liabilitiesUS$11.06b
Total assetsUS$19.53b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: LRCX's short term assets ($13.5B) exceed its short term liabilities ($5.3B).

Long Term Liabilities: LRCX's short term assets ($13.5B) exceed its long term liabilities ($5.7B).


Debt to Equity History and Analysis

Debt Level: LRCX has more cash than its total debt.

Reducing Debt: LRCX's debt to equity ratio has reduced from 89.5% to 58.8% over the past 5 years.

Debt Coverage: LRCX's debt is well covered by operating cash flow (105.7%).

Interest Coverage: LRCX earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies